BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhou YM, Yin ZF, Yang JM, Li B, Shao WY, Xu F, Wang YL, Li DQ. Risk factors for intrahepatic cholangiocarcinoma: A case-control study in China. World J Gastroenterol 2008; 14(4): 632-635 [PMID: 18203300 DOI: 10.3748/wjg.14.632]
URL: https://www.wjgnet.com/1007-9327/full/v14/i4/632.htm
Number Citing Articles
1
Hai‐Rim Shin, Jin‐Kyoung Oh, Eric Masuyer, Maria‐Paula Curado, Veronique Bouvard, Yue‐Yi Fang, Surapon Wiangnon, Banchob Sripa, Sung‐Tae Hong. Epidemiology of cholangiocarcinoma: An update focusing on risk factorsCancer Science 2010; 101(3): 579 doi: 10.1111/j.1349-7006.2009.01458.x
2
Alina Pascale, Olivier Rosmorduc, Jean-Charles Duclos-Vallée. New epidemiologic trends in cholangiocarcinomaClinics and Research in Hepatology and Gastroenterology 2023; 47(9): 102223 doi: 10.1016/j.clinre.2023.102223
3
Kyu Sik Jung, Kyeong Hyeon Chun, Gi Hong Choi, Hyae Min Jeon, Hye Sun Shin, Young Nyun Park, Jun Yong Park. Synchronous development of intrahepatic cholangiocarcinoma and hepatocellular carcinoma in different sites of the liver with chronic B-viral hepatitis: two case reportsBMC Research Notes 2013; 6(1) doi: 10.1186/1756-0500-6-520
4
Jeffrey S. Chang, Chia-Rung Tsai, Li-Tzong Chen, Fu-Sheng Wang. Medical Risk Factors Associated with Cholangiocarcinoma in Taiwan: A Population-Based Case-Control StudyPLoS ONE 2013; 8(7): e69981 doi: 10.1371/journal.pone.0069981
5
Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo. Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus InfectionClinical Gastroenterology and Hepatology 2010; 8(11): 924 doi: 10.1016/j.cgh.2010.06.032
6
Xiaofei Cheng, Feng Zhao, Dong Chen, Piao Yang, Weixiang Zhong, Xiangming Xu, Weilin Wang. Successful treatment of colorectal liver metastasis harboring intrahepatic cholangiocarcinomaMedicine 2018; 97(51): e13751 doi: 10.1097/MD.0000000000013751
7
Meng Sha, Seogsong Jeong, Xin Wang, Ying Tong, Jie Cao, Han-Yong Sun, Lei Xia, Ning Xu, Zhi-Feng Xi, Jian-Jun Zhang, Xiao-Ni Kong, Qiang Xia. Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinomaBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5420-z
8
Ping Wang, Yu He, Xiaodong Ma, Beiwang Sun, Binyuan Huang, Canhua Zhu, Yanmin Liu. Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct CarcinomaMedical Science Monitor 2015; 21: 2943 doi: 10.12659/MSM.894330
9
Jessica L. Petrick, Jake E. Thistle, Anne Zeleniuch-Jacquotte, Xuehong Zhang, Jean Wactawski-Wende, Alison L. Van Dyke, Meir J. Stampfer, Rashmi Sinha, Howard D. Sesso, Catherine Schairer, Lynn Rosenberg, Thomas E. Rohan, Kim Robien, Mark P. Purdue, Jenny N. Poynter, Julie R. Palmer, Christina C. Newton, Martha S. Linet, Linda M. Liao, I-Min Lee, Jill Koshiol, Cari M. Kitahara, Jonathan N. Hofmann, Barry I. Graubard, Edward Giovannucci, Michael J. Gaziano, Susan M. Gapstur, Neal D. Freedman, Dawn Q. Chong, Andrew T. Chan, Julie E. Buring, Laura Beane E. Freeman, Peter T. Campbell, Katherine A. McGlynn. Body Mass Index, Diabetes and Intrahepatic Cholangiocarcinoma Risk: The Liver Cancer Pooling Project and Meta-analysisAmerican Journal of Gastroenterology 2018; 113(10): 1494 doi: 10.1038/s41395-018-0207-4
10
Abigail Zabron, Robert J. Edwards, Shahid A. Khan. The challenge of cholangiocarcinoma: dissecting the molecular mechanisms of an insidious cancerDisease Models & Mechanisms 2013; 6(2): 281 doi: 10.1242/dmm.010561
11
Beihui Xue, Sunjie Wu, Mingyue Zhang, Junjie Hong, Bole Liu, Nina Xu, Qiqiang Zeng, Kun Tang, Xiangwu Zheng. A radiomic-based model of different contrast-enhanced CT phase for differentiate intrahepatic cholangiocarcinoma from inflammatory mass with hepatolithiasisAbdominal Radiology 2021; 46(8): 3835 doi: 10.1007/s00261-021-03027-6
12
Miaoyan Wei, Lisheng Lü, Peiyi Lin, Zhisheng Chen, Zhiwei Quan, Zhaohui Tang. Multiple cellular origins and molecular evolution of intrahepatic cholangiocarcinomaCancer Letters 2016; 379(2): 253 doi: 10.1016/j.canlet.2016.02.038
13
Hao Zhang, Biqing Zhu, He Zhang, Jianxin Liang, Wenting Zeng. HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-AnalysisBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/3417976
14
G. L. Tyson, S. Keihanian, H. B. El-Serag. Hilar Cholangiocarcinoma2013; : 17 doi: 10.1007/978-94-007-6473-6_2
15
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancyCurrent Problems in Surgery 2021; 58(2): 100854 doi: 10.1016/j.cpsurg.2020.100854
16
Linchao Ding, Shilong Ning, Weijian Hu, Yadong Xue, Shi’an Yu, Md Sayed Ali Sheikh. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular CarcinomaOxidative Medicine and Cellular Longevity 2022; 2022: 1 doi: 10.1155/2022/6595989
17
Umair Mahmood, Ahmed Abbass, Khurum Khan. Optimizing outcomes and personalizing care with targeted agents in advanced cholangiocarcinomaCancer Treatment Reviews 2024; 131: 102851 doi: 10.1016/j.ctrv.2024.102851
18
Gary M Clifford. Expanding the list of cancers recognized to be caused by infectious agentsJNCI: Journal of the National Cancer Institute 2024;  doi: 10.1093/jnci/djae185
19
Shao-Qiang Li, Li-Jian Liang, Yun-Peng Hua, Bao-Gang Peng, Dong Chen, Shun-Jun Fu. Bilateral liver resection for bilateral intrahepatic stonesWorld Journal of Gastroenterology 2009; 15(29): 3660-3663 doi: 10.3748/wjg.15.3660
20
Min Li, Jinzheng Li, Peizhi Li, Hongyang Li, Tianyi Su, Rongtao Zhu, Jianping Gong. Hepatitis B virus infection increases the risk of cholangiocarcinoma: A meta‐analysis and systematic reviewJournal of Gastroenterology and Hepatology 2012; 27(10): 1561 doi: 10.1111/j.1440-1746.2012.07207.x
21
Yiqi Wu, Tianzhen Wang, Shengqian Ye, Ran Zhao, Xiaohui Bai, Yingying Wu, Kenji Abe, Xiaoming Jin. Detection of hepatitis B virus DNA in paraffin-embedded intrahepatic and extrahepatic cholangiocarcinoma tissue in the northern Chinese populationHuman Pathology 2012; 43(1): 56 doi: 10.1016/j.humpath.2011.04.004
22
Ban Seok Lee, Eun-Cheol Park, Seung Woo Park, Chung Mo Nam, Jaehoon Roh. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: A case-control study in KoreaWorld Journal of Gastroenterology 2015; 21(2): 502-510 doi: 10.3748/wjg.v21.i2.502
23
Kun-Ming Chan, Chun-Yi Tsai, Chun-Nan Yeh, Ta-Sen Yeh, Wei-Chen Lee, Yi-Yin Jan, Miin-Fu Chen. Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrenceBMC Gastroenterology 2018; 18(1) doi: 10.1186/s12876-018-0912-x
24
Shun-ichi Ariizumi, Masakazu Yamamoto. Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitisSurgery Today 2015; 45(6): 682 doi: 10.1007/s00595-014-1031-0
25
Roongruedee Chaiteerakij, Ju Dong Yang, William S. Harmsen, Seth W. Slettedahl, Teresa A. Mettler, Zachary S. Fredericksen, Ray W. Kim, Gregory J. Gores, Rosebud O. Roberts, Janet E. Olson, Terry M. Therneau, Lewis R. Roberts. Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer RiskHepatology 2013; 57(2): 648 doi: 10.1002/hep.26092
26
Alan W. Hemming. Biliary Tract and Primary Liver TumorsSurgical Oncology Clinics of North America 2019; 28(4): 519 doi: 10.1016/j.soc.2019.06.012
27
Allyson K. Martínez, Kendal Jensen, Chad Hall, April O'Brien, Laurent Ehrlich, Tori White, Fanyin Meng, Tianhao Zhou, John Greene, Francesca Bernuzzi, Pietro Invernizzi, David E. Dostal, Terry Lairmore, Gianfranco Alpini, Shannon S. Glaser. Nicotine Promotes Cholangiocarcinoma Growth in Xenograft MiceThe American Journal of Pathology 2017; 187(5): 1093 doi: 10.1016/j.ajpath.2017.01.011
28
S. Ralphs, S. A. Khan. The role of the hepatitis viruses in cholangiocarcinomaJournal of Viral Hepatitis 2013; 20(5): 297 doi: 10.1111/jvh.12093
29
In Rae Cho, Sang-Wook Yi, Ja Sung Choi, Jee-Jeon Yi. Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean AdultsCancers 2022; 14(7): 1709 doi: 10.3390/cancers14071709
30
Jessica L. Petrick, Andrea A. Florio, Rohit Loomba, Katherine A. McGlynn. Have incidence rates of liver cancer peaked in the United States?Cancer 2020; 126(13): 3151 doi: 10.1002/cncr.32794
31
学河 朱. Typing, Risk Factors and Related Treatments of CholangiocarcinomaAdvances in Clinical Medicine 2014; 4(04): 74 doi: 10.12677/ACM.2014.44014
32
C. de Martel, M. Plummer, S. Franceschi. Cholangiocarcinoma: Descriptive epidemiology and risk factorsGastroentérologie Clinique et Biologique 2010; 34(3): 173 doi: 10.1016/j.gcb.2010.01.008
33
Felice Giuliante, Agostino Maria De Rose, Gennaro Nuzzo. Benign Tumors of the Liver2015; : 129 doi: 10.1007/978-3-319-12985-3_10
34
Beihui Xue, Sunjie Wu, Minghua Zheng, Huanchang Jiang, Jun Chen, Zhenghao Jiang, Tian Tian, Yifan Tu, Huanhu Zhao, Xian Shen, Kuvaneshan Ramen, Xiuling Wu, Qiyu Zhang, Qiqiang Zeng, Xiangwu Zheng. Development and Validation of a Radiomic-Based Model for Prediction of Intrahepatic Cholangiocarcinoma in Patients With Intrahepatic Lithiasis Complicated by Imagologically Diagnosed MassFrontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.598253
35
Ben-Dong Chen, Wen-Chao Zhao, Jian-Da Dong, Hui Sima. Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissuesMolecular Biology Reports 2014; 41(7): 4313 doi: 10.1007/s11033-014-3302-7
36
Ruben R. Plentz, Nisar P. Malek. Clinical presentation, risk factors and staging systems of cholangiocarcinomaBest Practice & Research Clinical Gastroenterology 2015; 29(2): 245 doi: 10.1016/j.bpg.2015.02.001
37
Nanna M. Uldall Torp, Simon B. Kristensen, Frank V. Mortensen, Jakob Kirkegård. Cholecystitis and risk of pancreatic, liver, and biliary tract cancer in patients undergoing cholecystectomyHPB 2020; 22(9): 1258 doi: 10.1016/j.hpb.2019.11.012
38
Shinichi Aishima, Tomohiro Iguchi, Nobuhiro Fujita, Akinobu Taketomi, Yoshihiko Maehara, Masazumi Tsuneyoshi, Yoshinao Oda. Histological and immunohistological findings in biliary intraepithelial neoplasia arising from a background of chronic biliary disease compared with liver cirrhosis of non‐biliary aetiologyHistopathology 2011; 59(5): 867 doi: 10.1111/j.1365-2559.2011.04011.x
39
Yanming Zhou, Yanfang Zhao, Bin Li, Jiyi Huang, Lupeng Wu, Donghui Xu, Jiamei Yang, Jia He. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysisBMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-289
40
Hao Li, Bin Hu, Zun-Qiang Zhou, Jiao Guan, Zheng-Yun Zhang, Guang-Wen Zhou. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studiesWorld Journal of Surgical Oncology 2015; 13(1) doi: 10.1186/s12957-015-0583-9
41
Rachel M. Lee, Shishir K. Maithel. Approaches and Outcomes to Distal CholangiocarcinomaSurgical Oncology Clinics of North America 2019; 28(4): 631 doi: 10.1016/j.soc.2019.06.014
42
Lian-Yuan Tao, Xiao-Dong He, Qiang Qu, Lei Cai, Wei Liu, Li Zhou, Shang-Ming Zhang. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case–control study in ChinaLiver International 2010; 30(2): 215 doi: 10.1111/j.1478-3231.2009.02149.x
43
Roongruedee Chaiteerakij, Wirichada Pan-ngum, Kittiyod Poovorawan, Ngamphol Soonthornworasiri, Sombat Treeprasertsuk, Kamthorn Phaosawasdi. Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide studyWorld Journal of Gastroenterology 2017; 23(39): 7160-7167 doi: 10.3748/wjg.v23.i39.7160
44
Andrea A. Florio, Jacques Ferlay, Ariana Znaor, David Ruggieri, Christian S. Alvarez, Mathieu Laversanne, Freddie Bray, Katherine A. McGlynn, Jessica L. Petrick. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012Cancer 2020; 126(11): 2666 doi: 10.1002/cncr.32803
45
Shao-Liang Han, Hong-Zhong Zhou, Jun Cheng, Sheng-Hong Lan, Pei-Chen Zhang, Zhe-Jing Chen, Qi-Qiang Zeng. Diagnosis and Surgical Treatment of Intrahepatic Hepatolithiasis Associated CholangiocarcinomaAsian Journal of Surgery 2009; 32(1): 1 doi: 10.1016/S1015-9584(09)60001-4
46
Hong-Yang Li, Shi-Ji Zhou, Min Li, Ding Xiong, Akanand Singh, Qing-Xi Guo, Chang-An Liu, Jian-Ping Gong. Diagnosis and Cure Experience of Hepatolithiasis-Associated Intrahepatic Cholangiocarcinoma in 66 PatientsAsian Pacific Journal of Cancer Prevention 2012; 13(2): 725 doi: 10.7314/APJCP.2012.13.2.725
47
Oliver Clements, Joseph Eliahoo, Jin Un Kim, Simon D. Taylor-Robinson, Shahid A. Khan. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysisJournal of Hepatology 2020; 72(1): 95 doi: 10.1016/j.jhep.2019.09.007
48
Tushar Patel. New insights into the molecular pathogenesis of intrahepatic cholangiocarcinomaJournal of Gastroenterology 2014; 49(2): 165 doi: 10.1007/s00535-013-0894-y
49
Chyng-Wen Fwu, Yin-Chu Chien, San-Lin You, Kenrad E. Nelson, Gregory D. Kirk, Hsu-Sung Kuo, Manning Feinleib, Chien-Jen Chen. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in TaiwanHepatology 2011; 53(4): 1217 doi: 10.1002/hep.24150
50
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014Annals of Hepatology 2018; 17(4): 604 doi: 10.5604/01.3001.0012.0929
51
Jun Yan, Tatsuo Kanda, Shuang Wu, Fumio Imazeki, Osamu Yokosuka. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, JapanHepatology Research 2012; 42(10): 974 doi: 10.1111/j.1872-034X.2012.01009.x
52
Yan Zhang, Zhuo Ying Li, Qiu Ming Shen, Jia Yi Tuo, Jing Yu Tan, Yu Ting Tan, Hong Lan Li, Yong Bing Xiang. A prospective cohort study of cigarette smoking, alcohol drinking and liver cancer incidence in Chinese menJournal of Digestive Diseases 2022; 23(8-9): 527 doi: 10.1111/1751-2980.13136
53
Ya-yong Li, Hao Li, Pin Lv, Gang Liu, Xiao-rong Li, Bu-ning Tian, Dao-jin Chen. Prognostic Value of Cirrhosis for Intrahepatic Cholangiocarcinoma After Surgical TreatmentJournal of Gastrointestinal Surgery 2011; 15(4): 608 doi: 10.1007/s11605-011-1419-8
54
W. F. Shen, W. Zhong, Q. Liu, C. J. Sui, Y. Q. Huang, J. M. Yang. Adjuvant Transcatheter Arterial Chemoembolization for Intrahepatic Cholangiocarcinoma after Curative Surgery: Retrospective Control StudyWorld Journal of Surgery 2011; 35(9): 2083 doi: 10.1007/s00268-011-1171-y
55
M. Tanaka, H. Tanaka, H. Tsukuma, A. Ioka, A. Oshima, T. Nakahara. Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virusJournal of Viral Hepatitis 2010; 17(10): 742 doi: 10.1111/j.1365-2893.2009.01243.x
56
Dietmar Tamandl, Beata Herberger, Birgit Gruenberger, Harald Puhalla, Markus Klinger, Thomas Gruenberger. Influence of Hepatic Resection Margin on Recurrence and Survival in Intrahepatic CholangiocarcinomaAnnals of Surgical Oncology 2008; 15(10): 2787 doi: 10.1245/s10434-008-0081-1
57
Qiao Wu, Xiao-Dong He, Lan Yu, Wei Liu, Lian-Yuan Tao. The Metabolic Syndrome and Risk Factors for Biliary Tract Cancer: A Case-control Study in ChinaAsian Pacific Journal of Cancer Prevention 2012; 13(5): 1963 doi: 10.7314/APJCP.2012.13.5.1963
58
海玲 乔. Progress in Treatment of Unresectable Intrahepatic CholangiocarcinomaAdvances in Clinical Medicine 2023; 13(12): 19815 doi: 10.12677/ACM.2023.13122790
59
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2017; : 605 doi: 10.1007/978-3-319-26956-6_31
60
Chia-Sheng Chu, Che-Chen Lin, Cheng-Yuan Peng, Po-Heng Chuang, Wen-Pang Su, Shih-Wei Lai, Hsuan-Ju Chen, Chi-Jung Chung, Hsueh-Chou Lai. Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?Medicine 2017; 96(34): e7785 doi: 10.1097/MD.0000000000007785
61
Yan-Jiun Huang, Alexander TH Wu, Hung-Yi Chiou, Ming-Tsang Chuang, Tzu-Ching Meng, Li-Nien Chien, Yun Yen. Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control studyOncotarget 2017; 8(4): 6642 doi: 10.18632/oncotarget.14254
62
Stefania De Lorenzo, Francesco Tovoli, Alessandro Mazzotta, Francesco Vasuri, Julien Edeline, Deborah Malvi, Karim Boudjema, Matteo Renzulli, Heithem Jeddou, Antonietta D’Errico, Bruno Turlin, Matteo Cescon, Thomas Uguen, Alessandro Granito, Astrid Lièvre, Giovanni Brandi. Non-Alcoholic Steatohepatitis as a Risk Factor for Intrahepatic Cholangiocarcinoma and Its Prognostic RoleCancers 2020; 12(11): 3182 doi: 10.3390/cancers12113182
63
Yasuhiro Ito, Takeshi Kenmochi, Tomohisa Egawa, Shinobu Hayashi, Atsushi Nagashima, Yuko Kitagawa. Diagnosis of Distal Cholangiocarcinoma after the Removal of CholedocholithiasisGastroenterology Research and Practice 2012; 2012: 1 doi: 10.1155/2012/396869
64
Chiara Braconi, Tushar Patel. Cholangiocarcinoma: New Insights into Disease Pathogenesis and BiologyInfectious Disease Clinics of North America 2010; 24(4): 871 doi: 10.1016/j.idc.2010.07.006
65
Ethan Kai Jun Tham, Ryan Yanzhe Lim, Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, Michelle Law, Elina Cho, Nicole Shu Ying Tang, Claire Shiying Tan, Benedix Kuan Loo Sim, En Ying Tan, Wen Hui Lim, Mei Chin Lim, Toru Nakamura, Pojsakorn Danpanichkul, Sakkarin Chirapongsathorn, Karn Wijarnpreecha, Hirokazu Takahashi, Asahiro Morishita, Ming-Hua Zheng, Alfred Kow, Mark Muthiah, Jia Hao Law, Daniel Q Huang. Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-AnalysisClinical Gastroenterology and Hepatology 2024;  doi: 10.1016/j.cgh.2024.09.028
66
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären KarzinomsDer Internist 2016; 57(12): 1191 doi: 10.1007/s00108-016-0128-5
67
Riham Katkhuda, Yun Shin Chun. Intrahepatic Cholangiocarcinoma2019; : 1 doi: 10.1007/978-3-030-22258-1_1
68
Li Jiang, Li-Sheng Jiang, Lu-Nan Yan, Fu-Yu Li, Wei Wang, Nan-Sheng Cheng, Tian-Fu Wen. Effects of Epidermal Growth Factor Receptor Inhibitor Genistein on Proliferative Cholangitis in RatsJournal of Surgical Research 2010; 162(1): 59 doi: 10.1016/j.jss.2009.04.048
69
Jun-hua LU, Jing ZHANG, Guang-shun YANG, Jun ZHAO, Ning YANG, Hai-bin ZHANG, Chun-feng SHI, Tian YANG. Diagnosis and treatment of long-term hepatolithiasis associated with intrahepatic cholangiocarcinomaAcademic Journal of Second Military Medical University 2009; 28(9): 1128 doi: 10.3724/SP.J.1008.2008.01128
70
William C. Palmer, Tushar Patel. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinomaJournal of Hepatology 2012; 57(1): 69 doi: 10.1016/j.jhep.2012.02.022
71
Ming‐Shian Tsai, Po‐Huang Lee, Cheng‐Li Lin, Chiao‐Ling Peng, Chia‐Hung Kao. Type II diabetes mellitus is associated with a reduced risk of cholangiocarcinoma in patients with biliary tract diseasesInternational Journal of Cancer 2015; 136(10): 2409 doi: 10.1002/ijc.29292
72
Sirio Fiorino, Letizia Bacchi-Reggiani, Dario de Biase, Adele Fornelli, Michele Masetti, Andrea Tura, Fabio Grizzi, Matteo Zanello, Laura Mastrangelo, Raffaele Lombardi, Giorgia Acquaviva, Luca di Tommaso, Arrigo Bondi, Michela Visani, Sergio Sabbatani, Laura Pontoriero, Carlo Fabbri, Andrea Cuppini, Annalisa Pession, Elio Jovine. Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic reviewWorld Journal of Gastroenterology 2015; 21(45): 12896-12953 doi: 10.3748/wjg.v21.i45.12896
73
Seogsong Jeong, Ying Tong, Meng Sha, Jinyang Gu, Qiang Xia. Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinomaOncotarget 2017; 8(10): 17292 doi: 10.18632/oncotarget.14079
74
Yong Eun Chung, Myeong-Jin Kim, Young Nyun Park, Jin-Young Choi, Ju Yeon Pyo, Young Chul Kim, Hyeon Je Cho, Kyung Ah Kim, Sun Young Choi. Varying Appearances of Cholangiocarcinoma: Radiologic-Pathologic CorrelationRadioGraphics 2009; 29(3): 683 doi: 10.1148/rg.293085729
75
Yoshito Ikematsu, Tsutomu Tomioka, Tsukasa Tsunoda, Yoshitsugu Tajima, Takashi Kanematsu. Hepatobiliary and Pancreatic Carcinogenesis in the Hamster2009; : 115 doi: 10.1007/978-4-431-87773-8_9
76
Murad Aljiffry, Mark J Walsh, Michele Molinari. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009World Journal of Gastroenterology 2009; 15(34): 4240-4262 doi: 10.3748/wjg.15.4240
77
Nikolaos Fragkou, Lazaros Sideras, Panteleimon Panas, Christos Emmanouilides, Emmanouil Sinakos. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence?World Journal of Gastroenterology 2021; 27(27): 4252-4275 doi: 10.3748/wjg.v27.i27.4252
78
Yan-Ming Zhou, Lu Cao, Bin Li, Xiu-Zhong Zhang, Zheng-Feng Yin. Expression of HBx protein in hepatitis B virus-infected intrahepatic cholangiocarcinomaHepatobiliary & Pancreatic Diseases International 2012; 11(5): 532 doi: 10.1016/S1499-3872(12)60219-7
79
Men-Bao Qian, Ying-Dan Chen, Song Liang, Guo-Jing Yang, Xiao-Nong Zhou. The global epidemiology of clonorchiasis and its relation with cholangiocarcinomaInfectious Diseases of Poverty 2012; 1(1) doi: 10.1186/2049-9957-1-4
80
A. Shin, S. Park, H.R. Shin, E.-H. Park, S.K. Park, J.-K. Oh, M.-K. Lim, B.Y. Choi, M. Boniol, P. Boffetta. Population attributable fraction of infection-related cancers in KoreaAnnals of Oncology 2011; 22(6): 1435 doi: 10.1093/annonc/mdq592
81
Lingyu Tian, Jiaqiang Ma, Lijie Ma, Bohao Zheng, Longzi Liu, Danjun Song, Yining Wang, Zhao Zhang, Qiang Gao, Kang Song, Xiaoying Wang. PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcomeWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-02082-5
82
Neil Bhardwaj, David M. Lloyd. Handbook of Gastrointestinal Cancer2012; : 182 doi: 10.1002/9781118423318.ch8
83
Yuenan Huang, Liuping You, Weimin Xie, Li Ning, Jinghe Lang. Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysisOncotarget 2017; 8(59): 100570 doi: 10.18632/oncotarget.20141
84
Aaron P. Thrift, Hashem B. El-Serag, Fasiha Kanwal. Global epidemiology and burden of HCV infection and HCV-related diseaseNature Reviews Gastroenterology & Hepatology 2017; 14(2): 122 doi: 10.1038/nrgastro.2016.176
85
Tarun Rustagi, Constantin A. Dasanu. Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and UpdatesJournal of Gastrointestinal Cancer 2012; 43(2): 137 doi: 10.1007/s12029-011-9284-y
86
P W Ewald. 99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Symbionts and immunopathology in chronic diseases: insights from evolutionClinical and Experimental Immunology 2010; 160(1): 27 doi: 10.1111/j.1365-2249.2010.04127.x
87
Philipp Heumann, Andreas Albert, Karsten Gülow, Denis Tümen, Martina Müller, Arne Kandulski. Current and Future Therapeutic Targets for Directed Molecular Therapies in CholangiocarcinomaCancers 2024; 16(9): 1690 doi: 10.3390/cancers16091690
88
Yan-Ming Zhou, Jia-Mei Yang, Bin Li, Zheng-Feng Yin, Feng Xu, Bin Wang, Peng Liu, Zhi-Min Li. Clinicopathologic characteristics of intrahepatic cholangiocarcinoma in patients with positive serum a-fetoproteinWorld Journal of Gastroenterology 2008; 14(14): 2251-2254 doi: 10.3748/wjg.14.2251
89
Shinichi Aishima, Yuki Tanaka, Yuichiro Kubo, Ken Shirabe, Yoshihiko Maehara, Yoshinao Oda. Bile duct adenoma and von Meyenburg complex‐like duct arising in hepatitis and cirrhosis: Pathogenesis and histological characteristicsPathology International 2014; 64(11): 551 doi: 10.1111/pin.12209
90
Gia L. Tyson, Hashem B. El-Serag. Risk factors for cholangiocarcinomaHepatology 2011; 54(1): 173 doi: 10.1002/hep.24351
91
Giuliana Cavalloni, Caterina Peraldo-Neia, Francesco Sassi, Giovanna Chiorino, Ivana Sarotto, Massimo Aglietta, Francesco Leone. Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutationBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2136-1
92
Rakesh Sahu, Praveen Sharma, Ajay Kumar. An Insight into Cholangiocarcinoma and Recent Advances in its TreatmentJournal of Gastrointestinal Cancer 2023; 54(1): 213 doi: 10.1007/s12029-021-00728-5
93
Mengge Li, Min Du, Hui Cong, Yuanyuan Gu, Yuan Fang, Jin Li, Yu Gan, Hong Tu, Jinyang Gu, Qiang Xia. Characterization of hepatitis B virus DNA integration patterns in intrahepatic cholangiocarcinomaHepatology Research 2021; 51(1): 102 doi: 10.1111/hepr.13580
94
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinomaJournal of Hepatology 2014; 60(6): 1268 doi: 10.1016/j.jhep.2014.01.021
95
Hao Liang, Jianbing Wang, Huijuan Xiao, Ding Wang, Wenqiang Wei, Youlin Qiao, Paolo Boffetta. Estimation of cancer incidence and mortality attributable to alcohol drinking in chinaBMC Public Health 2010; 10(1) doi: 10.1186/1471-2458-10-730
96
Wei-Feng Shen, Wei Zhong, Feng Xu, Tong Kan, Li Geng, Feng Xie, Cheng-Jun Sui, Jia-Mei Yang. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinomaWorld Journal of Gastroenterology 2009; 15(47): 5976-5982 doi: 10.3748/wjg.15.5976
97
Maria-Cristina Navas, Shannon Glaser, Harshil Dhruv, Scott Celinski, Gianfranco Alpini, Fanyin Meng. Hepatitis C Virus Infection and CholangiocarcinomaThe American Journal of Pathology 2019; 189(6): 1122 doi: 10.1016/j.ajpath.2019.01.018
98
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectivesDigestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
99
Zhen-Yu Liu, Yan-Ming Zhou, Le-Hua Shi, Zheng-Feng Yin. Risk factors of intrahepatic cholangiocarcinoma in patients with hepatolithiasis: a case-control studyHepatobiliary & Pancreatic Diseases International 2011; 10(6): 626 doi: 10.1016/S1499-3872(11)60106-9
100
Zhi-Yuan Mao, Guang-Qing Zhu, Mei Xiong, Li Ren, Li Bai. Prognostic value of neutrophil distribution in cholangiocarcinomaWorld Journal of Gastroenterology 2015; 21(16): 4961-4968 doi: 10.3748/wjg.v21.i16.4961
101
Sang Hoon Lee, Seung Woo Park. Inflammation and Cancer Development in Pancreatic and Biliary Tract CancerThe Korean Journal of Gastroenterology 2015; 66(6): 325 doi: 10.4166/kjg.2015.66.6.325
102
Yufei Zhu, Yunhai Zhu, Feng Cai, Jie Zhao, Feng Liu. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic CholangiocarcinomaCell Biochemistry and Biophysics 2015; 73(2): 455 doi: 10.1007/s12013-015-0665-x
103
Shinichi Aishima, Nobuhiro Fujita, Yohei Mano, Tomohiro Iguchi, Akinobu Taketomi, Yoshihiko Maehara, Yoshinao Oda, Masazumi Tsuneyoshi. p62+ Hyaline Inclusions in Intrahepatic Cholangiocarcinoma Associated With Viral Hepatitis or Alcoholic Liver DiseaseAmerican Journal of Clinical Pathology 2010; 134(3): 457 doi: 10.1309/AJCP53YVVJCNDZIR
104
Ankitha Sivanand, Durva Talati, Yash Kalariya, Priyansh Patel, Siddharth Kamal Gandhi. Associations of Liver Fluke Infection and Cholangiocarcinoma: A Scoping ReviewCureus 2023;  doi: 10.7759/cureus.46400
105
Paul W. Ewald. Natural History of Host-Parasite InteractionsAdvances in Parasitology 2009; 68: 21 doi: 10.1016/S0065-308X(08)00602-7
106
C H Lee, C J Chang, Y J Lin, C N Yeh, M F Chen, S Y Hsieh. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinomaBritish Journal of Cancer 2009; 100(11): 1765 doi: 10.1038/sj.bjc.6605063
107
Samuel O. Antwi, Omar Y. Mousa, Tushar Patel. Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014Annals of Hepatology 2018; 17(2): 274 doi: 10.5604/01.3001.0010.8659
108
Di Sun, Min Ding, Mengfan Ruan, Li Yang, Xingshun Qi. Hepatitis C - Recent Advances2023;  doi: 10.5772/intechopen.1001335
109
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract2016; : 1 doi: 10.1007/978-3-319-26587-2_31-1
110
Hogil Kim, Yun Kyung Chung, Inah Kim. Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in KoreaAnnals of Occupational and Environmental Medicine 2018; 30(1) doi: 10.1186/s40557-018-0217-0
111
Lei Zhang, Jian‐Qiang Cai, Jian‐Jun Zhao, Xin‐Yu Bi, Xiao‐Gang Tan, Tao Yan, Cong Li, Ping Zhao. Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinomaJournal of Surgical Oncology 2010; 101(3): 233 doi: 10.1002/jso.21488
112
Masakazu Yamamoto, Shun-ichi Ariizumi. Surgical outcomes of intrahepatic cholangiocarcinomaSurgery Today 2011; 41(7): 896 doi: 10.1007/s00595-011-4517-z
113
Paul W. Ewald, Holly A. Swain Ewald. Advances in Parasitology 2014; 84: 1 doi: 10.1016/B978-0-12-800099-1.00001-6
114
Sergio Hoyos, Maria-Cristina Navas, Juan-Carlos Restrepo, Rafael Claudino Botero. Current controversies in cholangiocarcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1461 doi: 10.1016/j.bbadis.2017.07.027
115
D Tamandl, K Kaczirek, B Gruenberger, C Koelblinger, J Maresch, R Jakesz, T Gruenberger. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinomaBritish Journal of Surgery 2009; 96(8): 919 doi: 10.1002/bjs.6654
116
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biologyFrontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
117
Nataliya Razumilava, Gregory J Gores. CholangiocarcinomaThe Lancet 2014; 383(9935): 2168 doi: 10.1016/S0140-6736(13)61903-0